Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Oxford Cannabinoid Technologies Holdings PLC - pharmaceutical company developing prescription cannabinoid medicines - Receives letter from Gavin Sathianathan, chair and CEO of GHS Capital Ltd, holder of 78.1 million shares in Oxford Cannabinoid, reflecting an 8.1% stake.
Letter requests a general meeting be convened to propose the removal of Neil Mahapatra, Julie Pomeroy, John Lucas, Cheryl Dhillon, Bishrut Mukherjee and Richard Hathaway as directors.
In addition, at the meeting, the shareholder will table a resolution proposing the appointment of James Brodie, Richard Bedford and Richard Grethe.
Oxford will call a general meeting within 21 days of receiving a valid requisition.
Current stock price: 2.17 pence
12-month change: down 57% since May 21, 2021
By Dayo Laniyan; dayolaniyan@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.